Dr. Keith Vossel provides input on the new FDA-approved Alzheimer’s drug lecanemab, marketed as Leqembi, in his interview with DailyMail.com on Jan 6, 2023.
FDA Approved the New Alzheimer's Drug, Marketed as Leqembi
Related Articles
Dr. Keith Vossel provides input on the new FDA-approved Alzheimer’s drug lecanemab, marketed as Leqembi, in his interview with DailyMail.com on Jan 6, 2023.